Patriot Financial Group Insurance Agency’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-18
Closed -$1K 1144
2022
Q2
$1K Sell
18
-481
-96% -$18.1K ﹤0.01% 1906
2022
Q1
$18K Buy
499
+5
+1% +$164 ﹤0.01% 1122
2021
Q4
$15K Sell
494
-364
-42% -$11.5K ﹤0.01% 1325
2021
Q3
$29K Buy
858
+140
+19% +$5.28K 0.01% 1062
2021
Q2
$29K Buy
718
+189
+36% +$7.4K 0.01% 1032
2021
Q1
$24K Buy
+529
New +$29.5K 0.01% 1022
2020
Q4
Sell
-6
Closed 1913
2020
Q3
$0 Hold
6
﹤0.01% 1753
2020
Q2
$0 Buy
+6
New +$334 ﹤0.01% 1742

Other funds holding IONS

Patriot Financial Group Insurance Agency's IONS Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Ionis Pharmaceuticals (IONS) in Q3 2022, closing a stake of 18 shares — an estimated $1K sold.

Patriot Financial Group Insurance Agency first reported a position in IONS in Q2 2020 and held it in 8 quarters. The position peaked at $29K in Q3 2021. 350 funds tracked by Wall St. Rank hold IONS as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Ionis Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 18 Ionis Pharmaceuticals shares in Q3 2022, an estimated $1K.
  • Patriot Financial Group Insurance Agency first reported a position in Ionis Pharmaceuticals in Q2 2020 and held it in 8 quarters.
  • Patriot Financial Group Insurance Agency's Ionis Pharmaceuticals position peaked at $29K in Q3 2021.
  • 350 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.